(Q84446925)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698503%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

A double-blind placebo-controlled multicentre study of sertraline in the acute and continuation treatment of major depression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698503%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

1 reference

J Olie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698503%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

K Gunn

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698503%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

E Katz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698503%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698503%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698503%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698503%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698503%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

34-41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698503%20AND%20SRC:MED&resulttype=core&format=json

Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2986377-8

7 January 2021

The Influence of Different Relapse Criteria on the Assessment of Long-Term Efficacy of Sertraline

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2986377-8

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2986377-8

7 January 2021

Treatment Received by Depressed Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2986377-8

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2986377-8

7 January 2021

Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2986377-8

7 January 2021

Sertraline in the prevention of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2986377-8

7 January 2021

Prophylaxis in recurrent unipolar depression: a new indication for treatment studies

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2986377-8

7 January 2021

Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2986377-8

7 January 2021

A double-blind, placebo-controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2986377-8

7 January 2021

Use of pattern analysis to identify true drug response. A replication

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2986377-8

7 January 2021

10.1016/S0924-9338(97)86377-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698503%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference